BETA


2019/2825(RSP) Resolution on Commission Implementing Regulation (EU) 2019/707 of 7 May 2019 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances alpha-cypermethrin, beflubutamid, benalaxyl, benthiavalicarb, bifenazate, boscalid, bromoxynil, captan, cyazofamid, desmedipham, dimethoate, dimethomorph, diuron, ethephon, etoxazole, famoxadone, fenamiphos, flumioxazine, fluoxastrobin, folpet, foramsulfuron, formetanate, metalaxyl-m, methiocarb, metribuzin, milbemectin, Paecilomyces lilacinus strain 251, phenmedipham, phosmet, pirimiphos-methyl, propamocarb, prothioconazole, s-metolachlor and tebuconazole

Progress: Procedure completed

RoleCommitteeRapporteurShadows
Lead ENVI HAZEKAMP Anja (icon: GUE/NGL GUE/NGL) HOJSÍK Martin (icon: Renew Renew)
Lead committee dossier:
Legal Basis:
RoP 112-p2

Events

2019/10/10
   EP - Motion for a resolution
Documents
2019/10/10
   EP - Decision by Parliament, 1st reading/single reading
Details

The European Parliament adopted by 402 votes to 222, with 39 abstentions, a resolution on Commission Implementing Regulation (EU) 2019/707 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances alphacypermethrin, beflubutamid, benalaxyl, benthiavalicarb, bifenazate, boscalid, bromoxynil, captan, cyazofamid, desmedipham, dimethoate, dimethomorph, diuron, ethephon, etoxazole, famoxadone, fenamiphos, flumioxazine, fluoxastrobin, folpet, foramsulfuron, formetanate, metalaxyl-m, methiocarb, metribuzin, milbemectin, Paecilomyces lilacinus strain 251, phenmedipham, phosmet, pirimiphos-methyl, propamocarb, prothioconazole, s-metolachlor and tebuconazole.

Parliament considered that Commission Implementing Regulation (EU) 2019/707 does not respect the precautionary principle. According to Members, the decision to Considers that the decision to extend the approval period for flumioxazine is not in line with the safety criteria laid down in Regulation (EC) No 1107/2009, and is based neither on evidence that this substance can safely be used, nor on a proven urgent need for the active substance flumioxazine for food production in the Union.

In support of its objection, Parliament stated that, in accordance with Regulation (EC) No 1272/2008 of the European Parliament and of the Council, flumioxazine has a harmonised classification of toxic for reproduction category 1B, very toxic to aquatic life and very toxic to aquatic life with long-lasting effects.

In addition, the European Food Safety Authority concluded already in 2014, and subsequently in 2017 and 2018, that there were critical areas of concern as flumioxazine is classified under reproductive toxicity category 1B and also that the potential endocrine disruption of flumioxazine was an issue that could not be finalised and a critical area of concern.

Members considered it is unacceptable that a substance which is known to meet the cut-off criteria for active substances that are mutagenic, carcinogenic and/or toxic for reproduction or that have endocrine-disrupting properties, which are set to protect human and environmental health, continues to be allowed for use in the Union, putting public and environmental health at risk.

In view of these elements, Parliament asked the Commission to:

- to repeal Commission Implementing Regulation (EU) 2019/707 and to submit a new draft to the committee that takes into account the scientific evidence on the harmful properties of all the substances concerned, especially those of flumioxazine;

- to present draft implementing regulations to extend the approval periods of substances for which the current state of science is not expected to lead to a Commission proposal for non-renewal of the authorisation of the active substance concerned;

- to withdraw the approvals for substances if proof or reasonable doubt exists that they will not meet the safety criteria laid down in Regulation (EC) No 1107/2009.

Member States are required to ensure the proper and timely reassessment of the authorisations of the active substances for which they are the reporting Member States and to ensure that the current delays are solved effectively as soon as possible.

Documents
2019/10/10
   EP - End of procedure in Parliament
2019/09/12
   EP - HAZEKAMP Anja (GUE/NGL) appointed as rapporteur in ENVI

Documents

Votes

B9-0103/2019 - Proposition de résolution

2019/10/10 Outcome: +: 402, -: 222, 0: 39
FR IT ES BG BE GB PT EL CY MT RO SK DK LV AT LU EE HR IE DE FI SI LT SE NL CZ HU PL
Total
66
65
44
13
19
65
21
19
6
6
26
12
12
8
17
5
3
10
10
86
12
7
10
19
26
19
17
40
icon: S&D S&D
140

Greece S&D

2

Cyprus S&D

2

Latvia S&D

2

Estonia S&D

For (1)

1

Slovenia S&D

For (1)

1

Lithuania S&D

2

Hungary S&D

For (1)

Abstain (1)

2
icon: Verts/ALE Verts/ALE
68

Spain Verts/ALE

2

Belgium Verts/ALE

3

Portugal Verts/ALE

1

Denmark Verts/ALE

2

Latvia Verts/ALE

1

Austria Verts/ALE

2

Luxembourg Verts/ALE

For (1)

1

Ireland Verts/ALE

For (1)

1

Finland Verts/ALE

2

Lithuania Verts/ALE

2

Sweden Verts/ALE

2

Netherlands Verts/ALE

3

Czechia Verts/ALE

3
icon: GUE/NGL GUE/NGL
39

Belgium GUE/NGL

For (1)

1

United Kingdom GUE/NGL

1

Cyprus GUE/NGL

2

Denmark GUE/NGL

1

Finland GUE/NGL

For (1)

1

Sweden GUE/NGL

For (1)

1

Netherlands GUE/NGL

For (1)

1

Czechia GUE/NGL

1
icon: ID ID
63

Belgium ID

2

Denmark ID

Against (1)

1

Austria ID

2

Finland ID

2

Czechia ID

2
icon: Renew Renew
97

Belgium Renew

Against (1)

Abstain (1)

4

Slovakia Renew

2

Denmark Renew

4

Latvia Renew

For (1)

1

Austria Renew

For (1)

1

Luxembourg Renew

2

Estonia Renew

2

Croatia Renew

For (1)

1

Ireland Renew

For (1)

1

Finland Renew

2

Slovenia Renew

For (1)

Abstain (1)

2

Lithuania Renew

2

Sweden Renew

3

Hungary Renew

2
icon: NI NI
48

Slovakia NI

2

Croatia NI

1

Germany NI

1

Hungary NI

1
icon: ECR ECR
49

Italy ECR

3

Spain ECR

2

Bulgaria ECR

2

Belgium ECR

2

Greece ECR

Against (1)

1

Slovakia ECR

2

Latvia ECR

2

Croatia ECR

For (1)

1

Lithuania ECR

Against (1)

1

Sweden ECR

For (1)

3

Netherlands ECR

4
icon: PPE PPE
159

Bulgaria PPE

Against (1)

4

Belgium PPE

Against (1)

4
2

Malta PPE

2

Slovakia PPE

For (1)

Against (1)

Abstain (1)

3

Denmark PPE

Against (1)

1

Latvia PPE

For (1)

Against (1)

2

Luxembourg PPE

Against (1)

2

Finland PPE

3

Slovenia PPE

For (1)

4

History

(these mark the time of scraping, not the official date of the change)

docs/0/docs/0/url
http://www.europarl.europa.eu/doceo/document/B-9-2019-0103_EN.html
docs/1
date
2019-10-10T00:00:00
docs
url: http://www.europarl.europa.eu/sides/getDoc.do?type=TA&language=EN&reference=P9-TA-2019-0026 title: T9-0026/2019
type
Text adopted by Parliament, single reading
body
EP
events/0
date
2019-10-10T00:00:00
type
Decision by Parliament, 1st reading/single reading
body
EP
docs
url: http://www.europarl.europa.eu/doceo/document/TA-9-2019-0026_EN.html title: T9-0026/2019
summary
events/0
date
2019-10-10T00:00:00
type
Decision by Parliament, 1st reading/single reading
body
EP
docs
url: http://www.europarl.europa.eu/sides/getDoc.do?type=TA&language=EN&reference=P9-TA-2019-0026 title: T9-0026/2019
docs
  • date: 2019-10-10T00:00:00 docs: title: B9-0103/2019 type: Motion for a resolution body: EP
  • date: 2019-10-10T00:00:00 docs: url: http://www.europarl.europa.eu/sides/getDoc.do?type=TA&language=EN&reference=P9-TA-2019-0026 title: T9-0026/2019 type: Text adopted by Parliament, single reading body: EP
events
  • date: 2019-10-10T00:00:00 type: Decision by Parliament, 1st reading/single reading body: EP docs: url: http://www.europarl.europa.eu/sides/getDoc.do?type=TA&language=EN&reference=P9-TA-2019-0026 title: T9-0026/2019
  • date: 2019-10-10T00:00:00 type: End of procedure in Parliament body: EP
procedure/stage_reached
Old
Awaiting Parliament 1st reading / single reading / budget 1st stage
New
Procedure completed
forecasts
  • date: 2019-10-10T00:00:00 title: Vote scheduled
forecasts/0/title
Old
Vote in plenary scheduled
New
Vote scheduled
forecasts/0/title
Old
Indicative plenary sitting date, 1st reading/single reading
New
Vote in plenary scheduled
procedure/title
Old
Objection pursuant to Rule 112: Extension of the approval periods of the active substances alpha-cypermethrin, beflubutamid, benalaxyl, benthiavalicarb, bifenazate, boscalid, bromoxynil, captan, cyazofamid, desmedipham, dimethoate, dimethomorph, diuron, ethephon, etoxazole, famoxadone, fenamiphos, flumioxazine, fluoxastrobin, folpet, foramsulfuron, formetanate, metalaxyl-m, methiocarb, metribuzin, milbemectin, Paecilomyces lilacinus strain 251, phenmedipham, phosmet, pirimiphos-methyl, propamocarb, prothioconazole, s-metolachlor and tebuconazole (D061354)
New
Resolution on Commission Implementing Regulation (EU) 2019/707 of 7 May 2019 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances alpha-cypermethrin, beflubutamid, benalaxyl, benthiavalicarb, bifenazate, boscalid, bromoxynil, captan, cyazofamid, desmedipham, dimethoate, dimethomorph, diuron, ethephon, etoxazole, famoxadone, fenamiphos, flumioxazine, fluoxastrobin, folpet, foramsulfuron, formetanate, metalaxyl-m, methiocarb, metribuzin, milbemectin, Paecilomyces lilacinus strain 251, phenmedipham, phosmet, pirimiphos-methyl, propamocarb, prothioconazole, s-metolachlor and tebuconazole